Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharma replaces CEO
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Pharma to sell more women's health assets for $1.38 billion | Reuters
Teva Pharmaceutical Industries Limited: Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir Digihaler (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022